HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

A TLR5 agonist enhances CD8(+) T cell-mediated graft-versus-tumor effect without exacerbating graft-versus-host disease.

Abstract
Allogeneic hematopoietic cell transplantation is an established treatment for hematologic and nonhematologic malignancies. Donor-derived immune cells can identify and attack host tumor cells, producing a graft-versus-tumor (GVT) effect that is crucial to the effectiveness of the transplantation therapy. CBLB502 is a novel agonist for TLR5 derived from Salmonella flagellin. On the basis of TLR5-mediated immunomodulatory function, we examined the effect of CBLB502 on GVT activity. Using two tumor models that do not express TLR5, and thereby do not directly respond to CBLB502, we found that CBLB502 treatment significantly enhanced allogeneic CD8(+) T cell-mediated GVT activity, which was evidenced by decreased tumor burden and improved host survival. Importantly, histopathologic analyses showed that CBLB502 treatment did not exacerbate the moderate graft-versus-host disease condition caused by the allogeneic CD8(+) T cells. Moreover, mechanistic analyses showed that CBLB502 stimulates CD8(+) T cell proliferation and enhances their tumor killing activity mainly indirectly through a mechanism that involves the IL-12 signaling pathway and the CD11c(+) and CD11b(+) populations in the bone marrow cells. This study demonstrates a new beneficial effect of CBLB502, and suggests that TLR5-mediated immune modulation may be a promising approach to improve GVT immunity without exacerbating graft-versus-host disease.
AuthorsXilai Ding, Guanglin Bian, Nicholas D Leigh, Jingxin Qiu, Philip L McCarthy, Hong Liu, Semra Aygun-Sunar, Lyudmila G Burdelya, Andrei V Gudkov, Xuefang Cao
JournalJournal of immunology (Baltimore, Md. : 1950) (J Immunol) Vol. 189 Issue 10 Pg. 4719-27 (Nov 15 2012) ISSN: 1550-6606 [Electronic] United States
PMID23045613 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Toll-Like Receptor 5
  • Flagellin
Topics
  • Animals
  • CD8-Positive T-Lymphocytes (immunology, pathology)
  • Cell Proliferation (drug effects)
  • Flagellin (chemistry, immunology, pharmacology)
  • Graft vs Host Disease (immunology, pathology)
  • Graft vs Tumor Effect (drug effects, immunology)
  • Hematopoietic Stem Cell Transplantation
  • Immunity, Cellular (drug effects, immunology)
  • Mice
  • Mice, Inbred BALB C
  • Mice, Inbred DBA
  • Neoplasms, Experimental (immunology, pathology, therapy)
  • Salmonella (chemistry)
  • Toll-Like Receptor 5 (agonists, immunology)
  • Transplantation, Homologous

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: